Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis

Gai Gao(First Affiliated Hospital of Henan University), Zhishen Xie(First Affiliated Hospital of Henan University), Erwen Li(First Affiliated Hospital of Henan University), Yong Yuan(First Affiliated Hospital of Henan University), Yu Fu(First Affiliated Hospital of Henan University), Pan Wang(First Affiliated Hospital of Henan University), Xiaowei Zhang(First Affiliated Hospital of Henan University), Yonghui Qiao(First Affiliated Hospital of Henan University), Jiangyan Xu(First Affiliated Hospital of Henan University), Christian Hölscher(First Affiliated Hospital of Henan University), Hui Wang(First Affiliated Hospital of Henan University), Zhenqiang Zhang(First Affiliated Hospital of Henan University)
Journal of Natural Medicines
February 15, 2021
Cited by 118

Abstract


Related Papers